Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
ARUP Laboratories, |
RCV000507943 | SCV000604493 | benign | not specified | 2016-09-29 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000507943 | SCV000732283 | likely benign | not specified | 2018-01-11 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Prevention |
RCV000679377 | SCV000806259 | likely benign | not provided | 2014-02-20 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002056910 | SCV002364122 | benign | Neurofibromatosis, type 1 | 2025-02-03 | criteria provided, single submitter | clinical testing | |
Sema4, |
RCV002256326 | SCV002527420 | benign | Hereditary cancer-predisposing syndrome | 2020-11-05 | criteria provided, single submitter | curation | |
Genome- |
RCV002056910 | SCV002561013 | benign | Neurofibromatosis, type 1 | 2022-03-15 | criteria provided, single submitter | clinical testing |